Hypersensitivity to monoclonal antibodies used for cancer and inflammatory or connective tissue diseases
Authors:
- 1 July 2019
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 123 (1) , 35-41
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid LeukemiaNew England Journal of Medicine, 2013
- Successful desensitization in a case of Stevens–Johnson syndrome due to vemurafenibMelanoma Research, 2012
- The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactoseJournal of Allergy and Clinical Immunology, 2011
- Acute generalised exanthematous pustulosis following intravitreal RanibizumabInternational Wound Journal, 2011
- Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinantJournal of Allergy and Clinical Immunology, 2009
- Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412New England Journal of Medicine, 2006
- Clinical features and severity grading of anaphylaxisJournal of Allergy and Clinical Immunology, 2004
- Mathematical and computational models of immune-receptor signallingNature Reviews Immunology, 2004
- Peroxide formation in polysorbate 80 and protein stabilityJournal of Pharmaceutical Sciences, 2002
- Histamine-releasing properties of Polysorbate 80in vitro andin vivo: correlation with its hypotensive action in the dogInflammation Research, 1985